ProPhase Labs, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)	Dec. 31, 2025 yr	Sep. 09, 2025 yr
Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liability, measurement input		0.57
Derivative liability, measurement input	0.76
Expected term (years)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liability, measurement input		1.0
Derivative liability, measurement input	0.6
Expected stock price volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liability, measurement input		0.992
Derivative liability, measurement input	1.250
Risk-free rate of interest
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liability, measurement input		0.036
Derivative liability, measurement input	0.035
Expected dividend yield (per share)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liability, measurement input		0
Derivative liability, measurement input	0